Terns Phar­ma­ceu­ti­cal­s' CEO Senthil Sun­daram steps down for health rea­sons

Terns Phar­ma­ceu­ti­cals CEO Senthil Sun­daram has re­signed from his po­si­tion for health rea­sons.

Terns dis­closed in an SEC fil­ing in Jan­u­ary of last year that Sun­daram had re­ceived a can­cer di­ag­no­sis and would “un­der­go ag­gres­sive treat­ment, in­clud­ing chemother­a­py.” At the time, Sun­daram planned to main­tain his du­ties as CEO dur­ing treat­ment, but would “lim­it cer­tain busi­ness ac­tiv­i­ties, in­clud­ing trav­el.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.